Validity and reliability of the Arabic version of topical corticosteroid phobia (TOPICOP^©) questionnaire.

IF 1.7 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Saudi Medical Journal Pub Date : 2025-03-01 DOI:10.15537/smj.2025.46.3.20240506

Hashem M Al-Dujaily, Huda A Hussein, Bahaa Abdelrahim, Mohammad Shawer, Ahmad Mehyar, Baha' Aljeradat, Dima Batarseh, Sarah Khraim, Amjad Abdeen, Noor Almaani

{"title":"Validity and reliability of the Arabic version of topical corticosteroid phobia (TOPICOP©) questionnaire.","authors":"Hashem M Al-Dujaily, Huda A Hussein, Bahaa Abdelrahim, Mohammad Shawer, Ahmad Mehyar, Baha' Aljeradat, Dima Batarseh, Sarah Khraim, Amjad Abdeen, Noor Almaani","doi":"10.15537/smj.2025.46.3.20240506","DOIUrl":null,"url":null,"abstract":"Objectives: To translate the topical corticosteroid phobia (TOPICOP) scale into Arabic and assess its validity, reliability, and feasibility.Methods: A cross-sectional study was carried out at Jordan University Hospital, Amman, Jordan, in 2 phases. Phase one involved translation of the TOPICOP scale into Arabic using a 2-step process, followed by pilot testing and content validation by 6 bilingual dermatologists. Phase 2 involved subsequent validation and feasibility testing on a larger sample of 145 participants. To assess reliability, the scale was administered twice for test-retest analysis.Results: Calculated content validity indices revealed satisfactory values, establishing content validation of the Arabic version. Cronbach's alpha coefficient indicated reliable internal consistency (0.757). Test-retest reliability yielded a Pearson's correlation coefficient of 0.775 (p<0.001). The mean global TOPICOP score was 56.4%. The scale was clear, feasible, and completed in under 5 minutes without difficulty.Conclusion: The Arabic TOPICOP scale is a valid, reliable, and effective tool for assessing corticosteroid phobia in Arabic-speaking populations. Its implementation can enhance understanding of patient adherence and improve eczema treatment outcomes, benefiting healthcare providers, including dermatologists, general practitioners, and family physicians.","PeriodicalId":21453,"journal":{"name":"Saudi Medical Journal","volume":"46 3","pages":"307-315"},"PeriodicalIF":1.7000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11918678/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Saudi Medical Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15537/smj.2025.46.3.20240506","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: To translate the topical corticosteroid phobia (TOPICOP) scale into Arabic and assess its validity, reliability, and feasibility.

Methods: A cross-sectional study was carried out at Jordan University Hospital, Amman, Jordan, in 2 phases. Phase one involved translation of the TOPICOP scale into Arabic using a 2-step process, followed by pilot testing and content validation by 6 bilingual dermatologists. Phase 2 involved subsequent validation and feasibility testing on a larger sample of 145 participants. To assess reliability, the scale was administered twice for test-retest analysis.

Results: Calculated content validity indices revealed satisfactory values, establishing content validation of the Arabic version. Cronbach's alpha coefficient indicated reliable internal consistency (0.757). Test-retest reliability yielded a Pearson's correlation coefficient of 0.775 (p<0.001). The mean global TOPICOP score was 56.4%. The scale was clear, feasible, and completed in under 5 minutes without difficulty.

Conclusion: The Arabic TOPICOP scale is a valid, reliable, and effective tool for assessing corticosteroid phobia in Arabic-speaking populations. Its implementation can enhance understanding of patient adherence and improve eczema treatment outcomes, benefiting healthcare providers, including dermatologists, general practitioners, and family physicians.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Saudi Medical Journal 医学-医学：内科

CiteScore

2.30

自引率

6.20%

发文量

203

审稿时长

12 months

期刊介绍： The Saudi Medical Journal is a monthly peer-reviewed medical journal. It is an open access journal, with content released under a Creative Commons attribution-noncommercial license. The journal publishes original research articles, review articles, Systematic Reviews, Case Reports, Brief Communication, Brief Report, Clinical Note, Clinical Image, Editorials, Book Reviews, Correspondence, and Student Corner.